Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Testosterone
|
M914 |
10 |
110 |
154 |
M914c.2019.01 (Bottled 190618)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Testosterone glucuronic acid
|
D507 |
1 |
141 |
198 |
D507d.2021.01 (Ampouled 200625)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Testosterone sulfate (Et3N salt)
|
D508 |
1 |
110 |
154 |
D508.2020.01 (Ampouled 110616)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Epitestosterone
|
D547 |
1 |
110 |
154 |
D547b.2021.01 (Ampouled 200908)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Epitestosterone sulfate triethylammonium salt
|
D605 |
1 |
110 |
154 |
D605.2019.02 (Ampouled 090429)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5α-Dihydrotestosterone
|
D680 |
10 |
110 |
154 |
D680.2020.01
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5α-Dihydrotestosterone glucuronide free acid
|
S006 |
1 |
141 |
198 |
S006.2019.01
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5α-Dihydrotestosterone sulfate
|
D609 |
1 |
110 |
154 |
D609.2020.01 (Ampouled 101109)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Androsterone
|
D550 |
10 |
110 |
154 |
D550c.2019.01 (Bottled 180307)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Androsterone glucuronide
|
D572 |
1 |
141 |
198 |
D572b.2021.01 (Ampouled 190117)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Androsterone sulfate (Na+ salt)
|
D610 |
1 |
110 |
154 |
D610b.2017.02 (Ampouled 100315)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Etiocholanolone
|
D551 |
1 |
110 |
154 |
D551c.2021.01 (Ampouled 190221)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Etiocholanolone glucuronide (Na+ salt)
|
D607 |
1 |
110 |
154 |
D607.2020.01 (Ampouled 090218)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Etiocholanolone sulfate
|
D608 |
1 |
110 |
154 |
D608.2020.01 (Ampouled 130508)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5α-Androstane-3α,17β-diol
|
D634 |
1 |
110 |
154 |
D634b.2021.01 (Ampouled 180920)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5α-Androstane-3α,17β-diol-17-β-glucuronic acid
|
S002 |
1 |
110 |
154 |
S002.2020.01
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5α-Androstane-3α,17β-diol-3-β-glucuronic acid
|
S004 |
1 |
141 |
198 |
S004.2017.02
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5α-Androstane-3β, 17β-diol
|
D635 |
1 |
141 |
198 |
D635.2019.02 (Ampouled 100816)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5β-Androstane-3α,17β-diol
|
D636 |
1 |
110 |
154 |
D636.2021.01 (Ampouled 181108)
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5β-Androstane-3α, 17β-diol-3-O-β-glucuronic acid
|
S003 |
1 |
141 |
198 |
S003b.2019.01
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
5β-Androstane-3β,17β-diol
|
D637 |
1 |
141 |
198 |
D637.2021.01 (Ampouled 100809)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d3-Testosterone
|
D546 |
1 |
141 |
198 |
D546.2019.01 (Ampouled 190926)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
16,16,17-d3-Testosterone glucuronide (sodium salt)
|
S036 |
1 |
110 |
154 |
S036.2020.01
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
16,16,17-d3-Testosterone sulfate
|
D506 |
1 |
141 |
198 |
D506b.2020.01 (Ampouled 200701)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
19-d3-Testosterone
|
D644 |
1 |
207 |
290 |
D644.2016.02 (Ampouled 071105)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d3-Epitestosterone
|
D548 |
1 |
141 |
198 |
D548.2020.03 (Ampouled 170323)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d4-Epitestosterone
|
S001 |
1 |
141 |
198 |
S001.2018.02 (Ampouled 170706)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d3-Epitestosterone sulfate
|
D591 |
1 |
141 |
198 |
D591.2021.01 (Ampouled 090521)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d3-5α-Dihydrotestosterone
|
D552 |
1 |
141 |
198 |
D552.2021.01 (Ampouled 110404)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d3-5α-Dihydrotestosterone glucuronide free acid
|
D573 |
1 |
141 |
198 |
D573b.2020.01 (Ampouled 201026)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d3-5α-Dihydrotestosterone sulfate
|
D590 |
1 |
141 |
198 |
D590.2016.02
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d4-Androsterone
|
D549 |
1 |
141 |
198 |
D549.2020.01 (Ampouled 141014)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d4-Androsterone glucuronic acid
|
D829 |
1 (ampoule) |
141 |
198 |
D829g.2021.01 (Ampouled 210422)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d4-Androsterone sulfate
|
D587 |
1 |
141 |
198 |
D587.2021.01 (Ampouled 101014)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d5-Etiocholanolone
|
D528 |
1 |
141 |
198 |
D528c.2020.01 (Ampouled 200102)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d5-Etiocholanolone sulfate (NEt3 salt)
|
D606 |
1 |
141 |
198 |
D606.2019.02 (Ampouled 100716)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d3-5α-Androstane-3α,17β-diol
|
D593 |
1 |
141 |
198 |
D593.2020.01 (Ampouled 170316)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d3-5α-Androstane-3β,17β-diol
|
D594 |
1 |
141 |
198 |
D594.2020.01 (Ampouled 081127)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d5-5β-Androstane-3α,17β-diol
|
D580 |
1 |
141 |
198 |
D580.2020.01 (Ampouled 200305)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
d5-5β-Androstane-3β,17β-diol
|
S014 |
1 |
110 |
154 |
S014.2020.01 (Ampouled 160630)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
5α-Androstane-3β,17β-diol-3-β-glucuronic acid
|
D678 |
1 |
141 |
198 |
D678b.2020.01
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
5α-Androstane-3β-ol-17-one-3-glucuronide Na+ salt
|
S031 |
1 |
110 |
154 |
S031.2019.01
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of testosterone and metabolites |
17α-Hydroxyprogesterone
|
S041 |
20 |
110 |
154 |
S041.2021.01 (Bottled 201021)
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
Nandrolone
|
S038 |
10 |
110 |
154 |
S038.2019.01
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
17β-Nandrolone glucuronide (K+ salt)
|
D861 |
1 |
207 |
290 |
D861.2017.04 (Ampouled 100805)
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
Nandrolone sulfate, sodium salt
|
D809 |
1 |
110 |
154 |
D809b.2019.01
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
17α-Nandrolone
|
D722 |
1 |
110 |
154 |
D722e.2021.01 (Ampouled 180621)
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
Epinandrolone sulfate TEA salt
|
D783 |
1 |
207 |
290 |
D783b.2020.01 (Bottled 190430)
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
19-Norandrosterone
|
D555 |
1 |
110 |
154 |
D555a.2017.03 (Ampouled 161020)
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
19-Norandrosterone glucuronide (Na+ salt)
|
D596 |
1 |
141 |
198 |
D596a.2021.01 (Ampouled 140821)
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
19-Norandrosterone sulfate (Et3N salt)
|
D841 |
1 |
110 |
154 |
D841b.2020.01 (Ampouled 110705)
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
19-Noretiocholanolone
|
D554 |
1 |
110 |
154 |
D554.2019.02 (Ampouled 140717)
|
Clinical testing›Ephedrine and related compounds |
(-)-Ephedrine hydrochloride
|
M924 |
100 |
141 |
198 |
M924.2021.01
|
Clinical testing›Endogenous steroids and metabolites›Nandrolone and metabolites |
19-Noretiocholanolone glucuronide (Na salt)
|
D595 |
1 |
141 |
198 |
D595a.2019.01 (Ampouled 100322)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of nandrolone and metabolites |
d3-17β-Nandrolone
|
D583 |
5 |
207 |
290 |
D583.2019.02 (Bottled 160913)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of nandrolone and metabolites |
d3-17β-Nandrolone sulfate (Et3N salt)
|
D782 |
1 |
141 |
198 |
D782b.2020.01 (Ampouled 090107)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of nandrolone and metabolites |
13C2-17β-Nandrolone
|
D679 |
5 |
171 |
240 |
D679.2019.01
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of nandrolone and metabolites |
d4-19-Norandrosterone
|
D584 |
1 |
141 |
198 |
D584c.2020.01 (Amouled 140731)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of nandrolone and metabolites |
d4-19-Norandrosterone glucuronide (Na+ salt)*
|
D898 |
1 |
110 |
154 |
D898b.2020.01 (Ampouled 200213)
|
Clinical testing›Endogenous steroids and metabolites›Deuterated internal standards of nandrolone and metabolites |
d4-19-Noretiocholanolone
|
D742 |
1 |
141 |
198 |
D742.2021.01 (Ampouled 090319)
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
(±)-Amphetamine hydrochloride
|
D736 |
50 |
141 |
198 |
D736c.2021.01 (Bottled 210511)
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
(±)-Amphetamine sulfate
|
D420 |
50 |
110 |
154 |
D420d.2019.02 (Bottled 150423)
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
d-(+)-Amphetamine sulfate
|
D961 |
50 |
141 |
198 |
D961.2019.01
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
(±)-4-Methylmethamphetamine hydrochloride
|
D963 |
20 |
171 |
240 |
D963.2020.01
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
(±)-Methamphetamine hydrochloride
|
D816 |
50 |
141 |
198 |
D816g.2021.02 (Bottled 210413)
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
S-(+)-Methamphetamine hydrochloride
|
D830 |
50 |
110 |
154 |
D830b.2020.01 (Bottled 170314)
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
(±)-3,4-Methylenedioxyamphetamine hydrochloride (MDA)
|
D842 |
50 |
110 |
154 |
D842
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
(±)-N-Methyl-3,4-methylenedioxyamphetamine hydrochloride (MDMA)
|
D792 |
50 |
141 |
198 |
D792f.2021.01 (Bottled 200707)
|
Clinical testing›Cocaine and related compounds |
Benzoylecgonine tetrahydrate
|
D745 |
50 |
141 |
198 |
D745
|
Clinical testing›Cocaine and related compounds |
Cocaine base
|
D826 |
50 |
141 |
198 |
D826b.2019.02 (Bottled 190814)
|
Clinical testing›Cocaine and related compounds |
Cocaine hydrochloride
|
D747 |
20 |
141 |
198 |
D747
|
Clinical testing›Cocaine and related compounds |
Ecgonine hydrochloride |
D746 |
50 |
141 |
198 |
D746
|
Clinical testing›Cocaine and related compounds |
Methyl ecgonine hydrochloride, monohydrate
|
D452 |
10 |
171 |
240 |
D452c.2020.01 (Bottled 160414)
|
Clinical testing›Ephedrine and related compounds |
(+)-Ephedrine hemihydrate
|
M723 |
100 |
141 |
198 |
M723.2021.01
|
Clinical testing›Opiates |
Methyl codeine
|
D924 |
10 |
110 |
154 |
D924.2020.01
|
Clinical testing›Ephedrine and related compounds |
dl-Norephedrine hydrochloride
|
M296 |
100 |
110 |
154 |
M296.2019.01
|
Clinical testing›Ephedrine and related compounds |
(+)-Norpseudoephedrine hydrochloride (Cathine)
|
M297 |
50 |
110 |
154 |
M297.2020.01
|
Clinical testing›Ephedrine and related compounds |
p-Hydroxyephedrine hydrochloride (Oxilifrine hydrochloride)
|
D892 |
5 |
110 |
154 |
D892b.2022.01
|
Clinical testing›Ephedrine and related compounds |
(-)-Methylephedrine hydrochloride
|
M243 |
20 |
110 |
154 |
M243b.2021.01 (Bottled 160810)
|
Clinical testing›Ephedrine and related compounds |
(-)-Pseudoephedrine base
|
D397 |
100 |
141 |
198 |
D397.2017.02 (Bottled 190220)
|
Clinical testing›Ephedrine and related compounds |
(+)-Pseudoephedrine hydrochloride
|
D775 |
50 |
110 |
154 |
D775b.2021.01 (Bottled 201117)
|
Clinical testing›Opiates |
Acetylcodeine base
|
D821 |
50 |
171 |
240 |
D821c.2020.01 (Bottled 150803)
|
Clinical testing›Opiates |
Buprenorphine base
|
D932 |
10 |
110 |
154 |
D932.2020.01 (Bottled 150915)
|
Clinical testing›Opiates |
d3-Codeine base |
D673 |
1 |
141 |
198 |
D673
|
Clinical testing›Opiates |
Codeine glucuronide
|
D694 |
0.1 |
141 |
198 |
D694.2020.01 (Ampouled 130430)
|
Clinical testing›Opiates |
d3-Codeine glucuronide
|
D695 |
0.1 |
207 |
290 |
D695.2021.01 (Ampouled 140807)
|
Clinical testing›Opiates |
Dihydrocodeine hydrogen tartrate
|
D823 |
50 |
141 |
198 |
D823.2017.02
|
Clinical testing›Opiates |
Hydrocodone
|
D988 |
20 |
110 |
154 |
D988.2021.01 (Bottled 160831)
|
Clinical testing›Opiates |
3-Monoacetylmorphine sulfamate
|
D766 |
20 |
110 |
154 |
D766
|
Clinical testing›Opiates |
6-Monoacetylmorphine base
|
D777 |
20 |
110 |
154 |
D777c.2020.01
|
Clinical testing›Opiates |
Morphine free base
|
D408 |
50 |
141 |
198 |
D408e.2020.01 (Bottled 180627)
|
Clinical testing›Opiates |
d3-Morphine base monohydrate
|
D709 |
1 |
141 |
198 |
D709.2018.01 (Ampouled 091102b)
|
Clinical testing›Opiates |
Morphine sulfate
|
D925 |
50 |
141 |
198 |
D925.2020.01 (Bottled 190814)
|
Clinical testing›Opiates |
Noscapine (Narcotine) base |
D831 |
50 |
141 |
198 |
D831
|
Clinical testing›Opiates |
Noscapine hydrochloride
|
D791 |
50 |
110 |
154 |
D791b.2019.01 (Bottled 171005)
|
Clinical testing›Opiates |
Oxycodone |
D987 |
20 |
141 |
198 |
D987
|
Clinical testing›Opiates |
Oxymorphone
|
D1038 |
10 |
141 |
198 |
D1038.2020.01
|
Clinical testing›Opiates |
Papaverine hydrochloride
|
D750 |
50 |
110 |
154 |
D750b.2021.01 (Bottled 180629)
|
Clinical testing›Opiates |
Pholcodine
|
D539 |
20 |
141 |
198 |
D539b.2020.01
|
Clinical testing›Opiates |
Thebaine base
|
D731 |
20 |
110 |
154 |
D731b.2018.03
|
Clinical testing›Miscellaneous |
Caffeine
|
M724 |
50 |
141 |
198 |
M724c.2019.01
|
Clinical testing›Miscellaneous |
Cannabidiol
|
D512 |
25 |
110 |
154 |
D512c.2021.01
|
Clinical testing›Miscellaneous |
Ketamine hydrochloride
|
D686 |
50 |
141 |
198 |
D686c.2021.02 (Bottled 210705)
|
Clinical testing›Miscellaneous |
Meperidine hydrochloride (pethidine)
|
D443 |
20 |
110 |
154 |
D443b.2021.01
|
Clinical testing›Miscellaneous |
Methadone hydrochloride
|
D425 |
20 |
110 |
154 |
D425b.2020.01 (Bottled 200402)
|
Clinical testing›Miscellaneous |
Salbutamol
|
M898 |
10 |
141 |
198 |
M898c.2021.01 (Bottled 190213)
|
Clinical testing›Miscellaneous |
d3-Salbutamol
|
D939 |
1 |
141 |
198 |
D939.2021.01 (Ampouled 120424)
|
Clinical testing›Miscellaneous |
Salmeterol hydroxynaphthoate
|
M904 |
50 |
141 |
198 |
M904.2018.03
|
Clinical testing›Miscellaneous |
Selegiline hydrochloride
|
D822 |
50 |
141 |
198 |
D822.2019.01
|
Clinical testing›Synthetic cannabinoids |
AM1220 1-[(1-Methylpiperidin-2-yl)methyl]-3-(1-naphthoyl)-indole
|
D982 |
20 |
110 |
154 |
D982.2017.02
|
Clinical testing›Synthetic cannabinoids |
AM2201 [1-(5-Fluoropentyl)-3-(1-napthoyl)-indole]
|
D983 |
20 |
110 |
154 |
D983.2018.02
|
Clinical testing›Synthetic cannabinoids |
N-Pentyl-3-(1-naphthoyl)indole
|
D955 |
20 |
141 |
198 |
D955.2019.01
|
Clinical testing›Synthetic cannabinoids |
JWH-210 [N-Pentyl-3-(4-ethyl-1-naphthoyl)indole]
|
D984 |
5 |
110 |
154 |
D984.2018.02
|
Clinical testing›Synthetic cannabinoids |
1-(5-Fluoro-pentyl)-3-(2,2,3,3-
tetramethylcyclopropoyl)indole
|
D1000 |
25 |
110 |
154 |
D1000.2019.02
|
Clinical testing›Endogenous steroids and metabolites›Testosterone and metabolites |
Epitestosterone glucuronide sodium salt
|
S035 |
1 |
110 |
154 |
S035.2021.01 (Ampouled 200520)
|
Clinical testing›Endogenous steroids and metabolites›Amphetamines |
(±)-4-Methylamphetamine hydrochloride
|
D895 |
10 |
171 |
240 |
D895b.2018.02
|
Clinical testing›Opiates |
Norethylmorphine hydrochloride
|
D1085 |
5 |
141 |
198 |
D1085.2021.01
|